Palantir Announces Hiring of First USG Chief Medical Officer
May 03 2021 - 6:30AM
Business Wire
Continues Momentum in Healthcare and Life Sciences
Palantir Technologies today announced the hiring of Dr William
J. Kassler, MD, MPH, as its first US Government Chief Medical
Officer, bringing years of clinical and public health expertise to
Palantir as it continues its expansion in the private and public
health sectors.
Dr. Kassler is joining Palantir from IBM Watson Health and
worked throughout his career at the intersection of clinical care
and population health. He will lead the Public Health and Life
Sciences teams across Palantir’s USG and international
business.
Over the past few years, Palantir has grown its healthcare
business and in recent months made significant new senior hires
with deep domain expertise in life sciences, pharmaceuticals, and
public health. Dr. Kassler and the expanded team will continue to
build on Palantir’s success in public and commercial healthcare
around the globe, putting its technology to work to solve the
world’s most important health problems.
“Palantir has played a key role in mitigating the global
Covid-19 pandemic, supporting more than 100 organizations in their
response to the pandemic, and helping the U.S. and the U.K with
vaccine distribution,” said Shyam Sankar, Palantir’s COO. “Palantir
software has also been used in drug discovery, biotechnology,
scientific research, and to mitigate disparities in public health.
Dr. Kassler will play a key role in ensuring our healthcare work
continues to prosper.”
“Palantir’s ability to lead so many international public health
initiatives from the start of this pandemic was truly impressive
and serves as a model for the type of technology investments
governments around the world need to make,” said Dr. Kassler. “I’m
inspired by Palantir’s mission and team, and excited to get to
work. To emerge from this pandemic stronger, society will need to
make significant improvements to how we approach public
health.”
Dr. Kassler was IBM Watson Health’s Deputy Chief Health Officer
and Chief Medical Officer for Government Health & Human
Services and led their population health efforts. Before joining
the private sector, he was Chief Medical Officer for the New
England Region of the Centers for Medicare and Medicaid Services
(CMS), and the State Health Officer for the New Hampshire
Department of Health and Human Services. Dr. Kassler started his
career at the Centers for Disease Control and Prevention (CDC).
He received his MD from the University of Massachusetts Medical
School, an MS in nutrition from Case Western Reserve University,
and an MPH from the University of California, Berkeley. He
completed a primary care internal medicine residency at Brown
University and was a Robert Wood Johnson Clinical Scholar at the
University of California, San Francisco.
About Palantir Technologies
Palantir Technologies is a software company that builds
enterprise data platforms for use by organizations with complex and
sensitive data environments. From building safer cars and planes,
to discovering new drugs and combating terrorism, Palantir helps
customers across the public, private, and nonprofit sectors
transform the way they use their data. Additional information is
available at https://www.palantir.com.
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended. These statements may relate to, but are not limited to,
Palantir’s expectations regarding our healthcare business and the
expected benefits of our software platforms. Forward-looking
statements are inherently subject to risks and uncertainties, some
of which cannot be predicted or quantified. Forward-looking
statements are based on information available at the time those
statements are made and were based on current expectations as well
as the beliefs and assumptions of management as of that time with
respect to future events. These statements are subject to risks and
uncertainties, many of which involve factors or circumstances that
are beyond our control. These risks and uncertainties include our
ability to meet the unique needs of our customer; the failure of
our platforms to satisfy our customer or perform as desired; the
frequency or severity of any software and implementation errors;
our platforms’ reliability; and our customer’s ability to modify or
terminate contracts. Additional information regarding these and
other risks and uncertainties is included in the filings we make
with the Securities and Exchange Commission from time to time.
Except as required by law, we do not undertake any obligation to
publicly update or revise any forward-looking statement, whether as
a result of new information, future developments, or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210503005142/en/
Lisa Gordon media@palantir.com
Palantir Technologies (NYSE:PLTR)
Historical Stock Chart
From Aug 2024 to Sep 2024
Palantir Technologies (NYSE:PLTR)
Historical Stock Chart
From Sep 2023 to Sep 2024